{"id":552036,"date":"2026-04-04T12:30:00","date_gmt":"2026-04-04T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=552036"},"modified":"2026-03-11T17:04:04","modified_gmt":"2026-03-11T16:04:04","slug":"liraglutide-semaglutide-e-tirzepatide-uma-base-de-evidencia-consideravel","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/liraglutide-semaglutide-e-tirzepatide-uma-base-de-evidencia-consideravel\/","title":{"rendered":"Liraglutide, semaglutide e tirzepatide: uma base de evid\u00eancia consider\u00e1vel"},"content":{"rendered":"\n<p><strong>A redu\u00e7\u00e3o de peso \u00e9 uma medida terap\u00eautica importante na preven\u00e7\u00e3o da diabetes. A pr\u00e9-diabetes caracteriza-se por um n\u00edvel elevado de a\u00e7\u00facar no sangue em jejum e\/ou toler\u00e2ncia \u00e0 glucose diminu\u00edda, mas ainda n\u00e3o manifesta diabetes. Em pessoas obesas, esta fase representa uma janela de tempo crucial para interven\u00e7\u00f5es terap\u00eauticas. A farmacoterapia com an\u00e1logos da incretina, para al\u00e9m do tratamento conservador, pode n\u00e3o s\u00f3 provocar uma redu\u00e7\u00e3o relevante do peso, mas tamb\u00e9m contribuir para a normaliza\u00e7\u00e3o dos n\u00edveis de glicose no sangue, como mostra a situa\u00e7\u00e3o do estudo.     <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fliraglutide-semaglutide-e-tirzepatide-uma-base-de-evidencia-consideravel%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>A redu\u00e7\u00e3o de peso \u00e9 uma medida terap\u00eautica importante na preven\u00e7\u00e3o da diabetes. A pr\u00e9-diabetes caracteriza-se por um n\u00edvel elevado de a\u00e7\u00facar no sangue em jejum e\/ou toler\u00e2ncia \u00e0 glucose&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fliraglutide-semaglutide-e-tirzepatide-uma-base-de-evidencia-consideravel%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":552040,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Mim\u00e9ticos da incretina para a obesidade e a pr\u00e9-diabetes  ","footnotes":""},"category":[11397,11521,11524,11403,11474,11551],"tags":[18634,90498,75355,12441,90500,90501,90503,90505,16142,17379,72458,77208],"powerkit_post_featured":[],"class_list":["post-552036","post","type-post","status-publish","format-standard","has-post-thumbnail","category-endocrinologia-e-diabetologia-2","category-estudos","category-formacao-continua","category-nutricao","category-prevencao-e-cuidados-de-saude","category-rx-pt","tag-liraglutide-pt-pt","tag-mimeticos-da-incretina","tag-mounjaro-pt-pt","tag-obesidade","tag-pre-diabetes-2","tag-prevencao-da-diabetes-2","tag-programa-de-estudos-step","tag-programa-surmount","tag-reducao-de-peso","tag-semaglutidea","tag-tirzepatide-pt-pt","tag-wegovy-pt-pt","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-12 00:05:41","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":552037,"slug":"liraglutida-semaglutida-y-tirzepatida-una-base-de-pruebas-considerable","post_title":"Liraglutida, semaglutida y tirzepatida: una base de pruebas considerable","href":"https:\/\/medizinonline.com\/es\/liraglutida-semaglutida-y-tirzepatida-una-base-de-pruebas-considerable\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/552036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=552036"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/552036\/revisions"}],"predecessor-version":[{"id":552044,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/552036\/revisions\/552044"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/552040"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=552036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=552036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=552036"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=552036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}